(IRBT) iRobot - Ratings and Ratios

iRobot Corporation is a leader in the design, construction, and distribution of robots and home innovation products globally. The company operates across multiple regions, including the United States, Europe, the Middle East, Africa, Japan, and other international markets. Its product portfolio includes advanced floor care solutions such as the Roomba series of vacuuming robots, which offer features like the Clean Base Automatic Dirt Disposal system. Additionally, iRobot provides a range of accessories and consumables for these products, including replacement parts and subscription services. The Braava line focuses on automatic mopping robots, complemented by various cleaning solutions and mopping pads. Beyond home cleaning, iRobot also offers educational robots like the Root, designed for coding and learning, and combo robots that integrate both vacuuming and mopping functionalities. The company distributes its products through a network of retailers, distributors, and online platforms, including its own website and app. iRobot has been a pioneer in the robotics industry since its inception in 1990 and is headquartered in Bedford, Massachusetts.

From a technical standpoint, iRobots stock (NASDAQ:IRBT) shows a 20-day average volume of 2,061,113 shares, with a last price of $7.27. The stocks moving averages indicate a recent decline, with the SMA 20 at $8.50, SMA 50 at $8.54, and SMA 200 at $8.66. The Average True Range (ATR) of 0.88 suggests moderate volatility. Fundamentally, the company has a market capitalization of $267.39 million, with a price-to-book ratio of 1.78 and a price-to-sales ratio of 0.17. However, the negative return on equity (-87.91%) and the absence of P/E ratios indicate significant challenges in profitability.

Over the next three months, iRobots stock is expected to face headwinds due to its declining moving averages and negative profitability metrics. The SMA 200 is above the current price, signaling potential resistance. The ATR suggests volatility, with possible price fluctuations between $6.39 and $8.15. Without a forward P/E ratio, investor confidence may remain subdued. The companys focus on innovation and market expansion could be pivotal in improving its financial health, but near-term stock performance may remain under pressure.